한글목차

개 관절염 치료 시장 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 24억 7,000만 달러에서 2026년에는 26억 달러로, CAGR 5.4%로 확대가 전망됩니다. 지난 수년간의 성장 요인으로는 반려견의 관절염 발병률 증가, 반려동물 보호자의 인식 개선, 동물용 의약품의 발전, 반려견 사육두수 증가, 동물병원 및 진료소 확대 등을 꼽을 수 있습니다.

개 관절염 치료 시장 규모는 향후 수년간, 꾸준한 성장이 전망됩니다. 2030년에는 31억 3,000만 달러에 달하며, CAGR은 4.7%에 달할 전망입니다. 예측 기간의 성장 요인으로는 표적 생물학적 치료법 개발, 수의학 분야에서의 정밀의료 도입 확대, 관절 복원 수술 기술 혁신, 온라인 및 소매 동물용 의약품의 성장, 줄기세포 및 PRP 연구에 대한 투자 증가 등을 꼽았습니다. 예측 기간 중 주요 동향으로는 비스테로이드성 항염증약(NSAIDs) 사용 증가, 글루코사민 및 콘드로이틴과 같은 관절 보조제의 보급 확대, 줄기세포 치료 및 혈소판풍부혈장(PRP) 치료의 성장, 개에 대한 최소침습 수술의 확대, 관절염 관리에서 물리치료와 감기 및 레이저 치료의 통합 등이 있습니다. 레이저 치료의 통합 등을 들 수 있습니다.

반려동물 양육률 증가는 향후 수년간 반려견 관절염 치료제 시장의 성장을 촉진할 것으로 예측됩니다. 반려동물 사육은 주로 실용적 목적이 아닌 오락적 목적으로 사육되는 가축화된 동물의 욕구, 복지, 반려동물로서의 역할을 충족시키기 위해 개인 또는 가정이 책임과 보살핌을 지는 것을 말합니다. 반려동물 양육 증가는 라이프스타일의 변화, 반려동물의 인간화, 가처분 소득 증가 등의 요인에 의해 촉진되고 있습니다. 반려견 관절염 치료는 보호자가 반려견의 관절염 증상을 관리 및 완화하고, 삶의 질 향상과 운동 기능 유지를 목적으로 이용됩니다. 예를 들어 캐나다에 본사를 둔 업계 단체인 캐나다 동물 건강 연구소에 따르면 2025년 4월 기준, 2024년 캐나다의개 사육 수는 약 720만 마리, 고양이는 820만 마리로 추정되며, 캐나다 가구의 절반 이상이 반려동물을 키우고 있는 것으로 나타났습니다. 따라서 반려동물 양육률 증가는개 관절염 치료제 시장의 성장을 지원하고 있습니다.

이 시장의 주요 기업은 반려견의 관절 건강과 이동성을 위해 베딤베토맙 주사와 같은 혁신적인 치료법을 개발하고 있습니다. 통증에 관여하는 신경성장인자(NGF)를 표적으로 하는 모노클로널 항체 주사제인 베딤베토맙은 FDA의 승인을 받았습니다. 예를 들어 2023년 5월, Zoetis Inc.는 개에 대한 최초의 모노클로널 항체 제제 '리브렐라'의 FDA 승인을 획득했습니다. 이 약은 골관절염의 통증 조절과 관련된개 NGF의 생물학적 활성을 억제합니다. 한 달에 한 번 피하 주사로 투여되는 리브렐라는 반려견의 골관절염 통증을 관리할 수 있는 편리하고 장기적인 해결책을 제공합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Canine arthritis treatment involves various medical and therapeutic approaches aimed at addressing the chronic condition characterized by inflammation and progressive cartilage deterioration in a dog's joints. The goal is to reduce pain and inflammation, preserve joint function, and slow down disease progression.

The primary treatments for canine arthritis include drugs, supplements, surgical procedures, and other interventions. Canine arthritis drugs are medications specifically formulated to alleviate symptoms and manage arthritis in dogs. These drugs can be administered orally, parenterally (such as injections), or through other routes, targeting conditions such as osteoarthritis, rheumatoid arthritis, osteochondrosis, and traumatic arthritis. They are distributed through veterinary clinics, hospitals, retail pharmacies, and online platforms, catering to various end-users such as veterinary hospitals, drug stores, and e-commerce platforms.

Tariffs have impacted the canine arthritis treatment market by increasing the cost of imported veterinary drugs, surgical equipment, and advanced biologics, particularly affecting regions such as north america and europe. This has created challenges for veterinary clinics and online pharmacies that rely on imported products. On the positive side, tariffs have stimulated local production and development of cost-effective treatment alternatives, driving innovation and encouraging domestic pharmaceutical manufacturing.

The canine arthritis treatment market research report is one of a series of new reports from The Business Research Company that provides canine arthritis treatment market statistics, including canine arthritis treatment industry global market size, regional shares, competitors with a canine arthritis treatment market share, detailed canine arthritis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the canine arthritis treatment industry. This canine arthritis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The canine arthritis treatment market size has grown strongly in recent years. It will grow from $2.47 billion in 2025 to $2.6 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to growing prevalence of canine arthritis, rising awareness among pet owners, advancements in veterinary pharmaceuticals, increase in dog population, expansion of veterinary clinics and hospitals.

The canine arthritis treatment market size is expected to see steady growth in the next few years. It will grow to $3.13 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to development of targeted biologic therapies, increasing adoption of precision medicine in veterinary care, innovation in surgical techniques for joint repair, growth of online and retail veterinary pharmacies, rising investment in stem cell and prp research. Major trends in the forecast period include rising adoption of non-steroidal anti-inflammatory drugs (nsaids), increased use of joint supplements like glucosamine and chondroitin, growth in stem cell therapy and platelet-rich plasma (prp) treatments, expansion of minimally invasive surgical procedures for dogs, integration of physical therapy and cold laser therapy in arthritis management.

The increasing pet ownership rate is expected to drive the growth of the canine arthritis treatment market in the coming years. Pet ownership refers to the responsibility and care assumed by individuals or households to meet the needs, well-being, and companionship of domesticated animals kept primarily for pleasure rather than utility. Rising pet ownership is driven by factors such as lifestyle changes, pet humanization, and higher disposable incomes. Canine arthritis treatments are used by pet owners to manage and alleviate arthritis symptoms in dogs, aiming to improve quality of life and maintain mobility. For example, in April 2025, according to the Canadian Animal Health Institute, a Canada-based trade association, Canada was home to an estimated 7.2 million dogs and 8.2 million cats in 2024, making pets an integral part of over half of Canadian households. Therefore, the rising pet ownership rate is supporting growth in the canine arthritis treatment market.

Leading companies in this market are innovating treatments such as bedinvetmab injections to address canine joint health and mobility. Bedinvetmab, a monoclonal antibody injection targeting nerve growth factor (NGF) involved in pain, has gained FDA approval. For instance, in May 2023, Zoetis Inc. received FDA approval for Librela, the first monoclonal antibody for dogs, which inhibits canine NGF's biological activity related to pain regulation in osteoarthritis. Administered monthly via subcutaneous injection, Librela offers a convenient, long-term solution for managing canine osteoarthritis pain.

In September 2024, Zoetis, a US-based animal health company specializing in veterinary pain management solutions, partnered with the Arthritis Foundation to raise awareness about osteoarthritis (OA) in pets. This collaboration aims to support educational initiatives that help pet owners identify OA symptoms in dogs and cats, providing tools to improve early detection and manage OA-related pain effectively. The Arthritis Foundation is a US-based nonprofit organization dedicated to the prevention, control, and cure of America's leading cause of disability.

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill's Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

North America was the largest region in the canine arthritis treatment market in 2025. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the canine arthritis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The canine arthritis treatment market includes revenues earned by entities by providing services such as extracorporeal shockwave therapy (ESWT), acupuncture, and hyaluronic acid supplements. The market value includes the value of related goods sold by the service provider or included within the service offering. The canine arthritis treatment market also includes sales of gabapentin, adequan canine, and metacam. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Canine Arthritis Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses canine arthritis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for canine arthritis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The canine arthritis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Treatment Type: Drugs; Supplements; Surgical Procedures; Other Treatment Types
• 2) By Route Of Administration: Oral; Parenteral; Other Routes Of Administrations
• 3) By Arthritis Type: Osteoarthritis; Rheumatoid Arthritis; Osteochondrosis; Traumatic Arthritis
• 4) By Distribution Channels: Veterinary Clinics And Hospitals; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Disease-Modifying Osteoarthritis Drugs (DMOADs); Corticosteroids; Analgesics And Pain Relievers
• 2) By Supplements: Glucosamine And Chondroitin Supplements; Omega-3 Fatty Acids And Fish Oil; Hyaluronic Acid Supplements; MSM (Methylsulfonylmethane) Supplements; Collagen-Based Supplements
• 3) By Surgical Procedures: Joint Replacement Surgery; Arthroscopy; Osteotomy; Synovectomy
• 4) By Other Treatment Types: Physical Therapy; Stem Cell Therapy; Platelet-Rich Plasma (PRP) Therapy; Cold Laser Therapy (Low-Level Laser Therapy); Acupuncture
• Companies Mentioned: Merck & Co. Inc.; Bayer AG; Eli Lilly and Company; Zoetis Inc.; Boehringer Ingelheim Animal Health; Elanco Animal Health Incorporated; Royal Canin SAS; Virbac Group; Ceva Sante Animale S.A.; Hill's Pet Nutrition Inc.; Vetoquinol SA; Norbrook Laboratories Limited; American Regent Inc.; Thorne Healthtech Inc.; VetStem Inc.; Eltech K-Laser s.r.l.; Liquid Health Inc; Nutri-Vet LLC; OrthoPets LLC; Rejuvenate Bio Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Canine Arthritis Treatment Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Canine Arthritis Treatment Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Canine Arthritis Treatment Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Canine Arthritis Treatment Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Non-Steroidal Anti-Inflammatory Drugs (Nsaids)
  • 4.2.2 Increased Use Of Joint Supplements Like Glucosamine And Chondroitin
  • 4.2.3 Growth In Stem Cell Therapy And Platelet-Rich Plasma (Prp) Treatments
  • 4.2.4 Expansion Of Minimally Invasive Surgical Procedures For Dogs
  • 4.2.5 Integration Of Physical Therapy And Cold Laser Therapy In Arthritis Management

5. Canine Arthritis Treatment Market Analysis Of End Use Industries

• 5.1 Veterinary Clinics And Hospitals
• 5.2 Retail Pharmacies
• 5.3 Online Pharmacies
• 5.4 Pet Owners
• 5.5 Animal Rehabilitation Centers

6. Canine Arthritis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Canine Arthritis Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Canine Arthritis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Canine Arthritis Treatment Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Canine Arthritis Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Canine Arthritis Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Canine Arthritis Treatment Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Canine Arthritis Treatment Market Segmentation

• 9.1. Global Canine Arthritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Drugs, Supplements, Surgical Procedures, Other Treatment Types
• 9.2. Global Canine Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Parenteral, Other Routes Of Administrations
• 9.3. Global Canine Arthritis Treatment Market, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis
• 9.4. Global Canine Arthritis Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies
• 9.5. Global Canine Arthritis Treatment Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers
• 9.6. Global Canine Arthritis Treatment Market, Sub-Segmentation Of Supplements, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements
• 9.7. Global Canine Arthritis Treatment Market, Sub-Segmentation Of Surgical Procedures, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy
• 9.8. Global Canine Arthritis Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

10. Canine Arthritis Treatment Market Regional And Country Analysis

• 10.1. Global Canine Arthritis Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Canine Arthritis Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Canine Arthritis Treatment Market

• 11.1. Asia-Pacific Canine Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Canine Arthritis Treatment Market

• 12.1. China Canine Arthritis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Canine Arthritis Treatment Market

• 13.1. India Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Canine Arthritis Treatment Market

• 14.1. Japan Canine Arthritis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Canine Arthritis Treatment Market

• 15.1. Australia Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Canine Arthritis Treatment Market

• 16.1. Indonesia Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Canine Arthritis Treatment Market

• 17.1. South Korea Canine Arthritis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Canine Arthritis Treatment Market

• 18.1. Taiwan Canine Arthritis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Canine Arthritis Treatment Market

• 19.1. South East Asia Canine Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Canine Arthritis Treatment Market

• 20.1. Western Europe Canine Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Canine Arthritis Treatment Market

• 21.1. UK Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Canine Arthritis Treatment Market

• 22.1. Germany Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Canine Arthritis Treatment Market

• 23.1. France Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Canine Arthritis Treatment Market

• 24.1. Italy Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Canine Arthritis Treatment Market

• 25.1. Spain Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Canine Arthritis Treatment Market

• 26.1. Eastern Europe Canine Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Canine Arthritis Treatment Market

• 27.1. Russia Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Canine Arthritis Treatment Market

• 28.1. North America Canine Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Canine Arthritis Treatment Market

• 29.1. USA Canine Arthritis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Canine Arthritis Treatment Market

• 30.1. Canada Canine Arthritis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Canine Arthritis Treatment Market

• 31.1. South America Canine Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Canine Arthritis Treatment Market

• 32.1. Brazil Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Canine Arthritis Treatment Market

• 33.1. Middle East Canine Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Canine Arthritis Treatment Market

• 34.1. Africa Canine Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Canine Arthritis Treatment Market, Segmentation By Treatment Type, Segmentation By Route Of Administration, Segmentation By Arthritis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Canine Arthritis Treatment Market Regulatory and Investment Landscape

36. Canine Arthritis Treatment Market Competitive Landscape And Company Profiles

• 36.1. Canine Arthritis Treatment Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Canine Arthritis Treatment Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Canine Arthritis Treatment Market Company Profiles
  • 36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Boehringer Ingelheim Animal Health Overview, Products and Services, Strategy and Financial Analysis

37. Canine Arthritis Treatment Market Other Major And Innovative Companies

• Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill's Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

38. Global Canine Arthritis Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Canine Arthritis Treatment Market

40. Canine Arthritis Treatment Market High Potential Countries, Segments and Strategies

• 40.1 Canine Arthritis Treatment Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Canine Arthritis Treatment Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Canine Arthritis Treatment Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer